Webdisclosure.com

RELIEF THERAPEUTICS HOLDINGS AG (NASDAQ:RLFTF)

22/03/2023 07:00

Relief Therapeutics Announces Survey Results Identifying Preferred Urea Cycle Disorder Treatment Attributes Presented by Collaboration Partner at SIMD 2023

Voir tous les communiqués de Relief Therapeutics Holdings AG

RELIEF THERAPEUTICS HOLDINGS AG (NASDAQ:RLFTF)

17/03/2023 22:45

Relief Therapeutics to Present Pre-Clinical Evidence for Improved Amino Acid Utilization with PKU GOLIKE at the Society for Inherited Metabolic Disorders 44th Annual Meeting

Voir tous les communiqués de Relief Therapeutics Holdings AG

RELIEF THERAPEUTICS HOLDINGS AG (NASDAQ:RLFTF)

16/03/2023 07:00

Relief Therapeutics Announces Availability of New PKU GOLIKE BARs in Europe

Voir tous les communiqués de Relief Therapeutics Holdings AG

RELIEF THERAPEUTICS HOLDINGS AG (NASDAQ:RLFTF)

15/03/2023 07:00

Relief Therapeutics Provides Update From Collaboration Partner on OLPRUVA™

Voir tous les communiqués de Relief Therapeutics Holdings AG

RELIEF THERAPEUTICS HOLDINGS AG (NASDAQ:RLFTF)

28/02/2023 07:00

Relief Therapeutics Recognizes Rare Disease Day and Announces U.S. Availability of New PKU GOLIKE Bars

Voir tous les communiqués de Relief Therapeutics Holdings AG

RELIEF THERAPEUTICS HOLDINGS AG (NASDAQ:RLFTF)

14/02/2023 07:00

Relief Therapeutics Announces Enrollment of First Three Patients in Proof-of-Concept Clinical Trial of RLF-TD011 for the Treatment of Epidermolysis Bullosa

Voir tous les communiqués de Relief Therapeutics Holdings AG

RELIEF THERAPEUTICS HOLDINGS AG (NASDAQ:RLFTF)

08/02/2023 07:00

Relief Therapeutics Provides an Update on its Financing Strategy

Voir tous les communiqués de Relief Therapeutics Holdings AG

RELIEF THERAPEUTICS HOLDINGS AG (NASDAQ:RLFTF)

17/01/2023 06:56

Relief Therapeutics Announces IRB Approval of Investigator-Initiated Trial Evaluating RLF-TD011 as an Adjunctive Treatment for Cutaneous T-Cell Lymphom

Voir tous les communiqués de Relief Therapeutics Holdings AG

RELIEF THERAPEUTICS HOLDINGS AG (NASDAQ:RLFTF)

27/12/2022 07:15

Relief Therapeutics Files Amendment No. 2 to its Registration Statement on Form F-1 with the U.S. Securities and Exchange Commission

Voir tous les communiqués de Relief Therapeutics Holdings AG

RELIEF THERAPEUTICS HOLDINGS AG (NASDAQ:RLFTF)

27/12/2022 07:00

Acer Therapeutics and Relief Therapeutics Announce U.S. FDA Approval of OLPRUVA™ for Patients with Urea Cycle Disorders

Voir tous les communiqués de Relief Therapeutics Holdings AG

1
2
3
4
5
6
7
8
9
10